Department of Maternal and Child Health and Urology, Sapienza University of Rome, Rome, Italy.
Unit of Dermatology, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Ital J Pediatr. 2022 Jun 13;48(1):93. doi: 10.1186/s13052-022-01296-5.
COVID toes or chilblain-like skin lesions have been widely reported during COVID-19 pandemic. Most cases were described in patients with negative microbiological tests for SARS-CoV-2, therefore the possible relationship with SARS-CoV-2 infection, as well as with the nowadays broadly available mRNA-based vaccination, has not been fully elucidated. CASE PRESENTATION: We here describe the case of a 14-year-old male who developed chilblain-like skin eruptions during SARS-CoV-2 infection despite two mRNA-based vaccine doses and review the clinical and epidemiological characteristics of chilblain-like lesions as a cutaneous presentation of COVID-19 in children.
Most children and adolescent with COVID toes have a mild or asymptomatic SARS-CoV-2 infection. Our report aims to highlight the possible onset of these skin lesions in vaccinated children, if infection has occurred, and the potential use of systemic corticosteroids as a first line treatment. Additional evidence is required to better understand SARS-CoV-2 infection and cutaneous manifestations in children and determine the relationship between chilblain-like lesions and COVID-19 vaccination.
COVID 脚趾或冻疮样皮肤病变在 COVID-19 大流行期间已被广泛报道。大多数病例发生在 SARS-CoV-2 微生物检测阴性的患者中,因此,与 SARS-CoV-2 感染的可能关系,以及目前广泛使用的基于 mRNA 的疫苗接种,尚未完全阐明。
我们在此描述了一名 14 岁男性的病例,他在 SARS-CoV-2 感染期间出现冻疮样皮肤疹,尽管他已接种了两剂基于 mRNA 的疫苗,并回顾了儿童 COVID-19 以冻疮样病变为皮肤表现的临床和流行病学特征。
大多数 COVID 脚趾的儿童和青少年 SARS-CoV-2 感染较轻或无症状。我们的报告旨在强调如果发生感染,这些皮肤病变可能在接种疫苗的儿童中出现,以及全身性皮质类固醇作为一线治疗的潜在用途。需要更多的证据来更好地了解儿童的 SARS-CoV-2 感染和皮肤表现,并确定冻疮样病变与 COVID-19 疫苗接种之间的关系。